435 related articles for article (PubMed ID: 19345283)
1. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
3. Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Saito S; Ohshiro H; Kakuta Y; Nakajima A
Gastrointest Endosc; 2007 Dec; 66(6):1142-51. PubMed ID: 18061714
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
Nishimori I; Otsuki M
Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
[TBL] [Abstract][Full Text] [Related]
5. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis.
Sah RP; Chari ST; Pannala R; Sugumar A; Clain JE; Levy MJ; Pearson RK; Smyrk TC; Petersen BT; Topazian MD; Takahashi N; Farnell MB; Vege SS
Gastroenterology; 2010 Jul; 139(1):140-8; quiz e12-3. PubMed ID: 20353791
[TBL] [Abstract][Full Text] [Related]
6. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Kamisawa T; Okamoto A; Wakabayashi T; Watanabe H; Sawabu N
Scand J Gastroenterol; 2008; 43(5):609-13. PubMed ID: 18415756
[TBL] [Abstract][Full Text] [Related]
7. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
[TBL] [Abstract][Full Text] [Related]
8. The natural course of autoimmune pancreatitis.
Kamisawa T; Anjiki H; Takuma K; Egawa N; Kubota N
Hepatogastroenterology; 2009; 56(91-92):866-70. PubMed ID: 19621719
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune pancreatitis in Hungary: a multicenter nationwide study.
Czakó L; Gyökeres T; Topa L; Sahin P; Takács T; Vincze A; Dubravcsik Z; Szepes A; Pap A; Földesi I; Terzin V; Tiszlavicz L; Wittmann T
Pancreatology; 2011; 11(2):261-7. PubMed ID: 21625197
[TBL] [Abstract][Full Text] [Related]
10. [Autoimmune pancreatitis associated with rheumatoid arthritis: successful combination therapy with steroids and methotrexate].
Mustak M; Boltuch-Sherif J; Horvath-Mechtler B; Kowalski-Bodzenta J; Erlacher L
Dtsch Med Wochenschr; 2011 Sep; 136(37):1842-4. PubMed ID: 21898275
[TBL] [Abstract][Full Text] [Related]
11. Relapse rate and predictors of relapse in a large single center cohort of type 1 autoimmune pancreatitis: long-term follow-up results after steroid therapy with short-duration maintenance treatment.
Lee HW; Moon SH; Kim MH; Cho DH; Jun JH; Nam K; Song TJ; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol; 2018 Aug; 53(8):967-977. PubMed ID: 29362937
[TBL] [Abstract][Full Text] [Related]
12. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of swollen duodenal papilla in autoimmune pancreatitis.
Kubota K; Iida H; Fujisawa T; Ogawa M; Inamori M; Saito S; Kakuta Y; Oshiro H; Nakajima A
Pancreas; 2007 Nov; 35(4):e51-60. PubMed ID: 18090232
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis.
Naitoh I; Nakazawa T; Ohara H; Ando T; Hayashi K; Tanaka H; Okumura F; Miyabe K; Yoshida M; Sano H; Takada H; Joh T
Pancreas; 2010 Jan; 39(1):e1-5. PubMed ID: 19924018
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
[TBL] [Abstract][Full Text] [Related]
17. A new diagnostic endoscopic tool for autoimmune pancreatitis.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A
Gastrointest Endosc; 2008 Aug; 68(2):358-61. PubMed ID: 18513718
[TBL] [Abstract][Full Text] [Related]
18. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
Johnson PJ; McFarlane IG; Williams R
N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis.
Buechter M; Klein CG; Kloeters C; Schlaak JF; Canbay A; Gerken G; Kahraman A
Z Gastroenterol; 2014 Jun; 52(6):564-8. PubMed ID: 24905108
[TBL] [Abstract][Full Text] [Related]
20. Remission and relapse of autoimmune pancreatitis: focusing on corticosteroid treatment.
Kim HM; Chung MJ; Chung JB
Pancreas; 2010 Jul; 39(5):555-60. PubMed ID: 20182397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
